![Joseph Loscalzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Loscalzo
Président chez
IONIS PHARMACEUTICALS, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Le Dr Joseph Loscalzo, MD PhD, est conseiller chez Mi3 Venture Partners Management LLC. Il est professeur Wade et président du département de médecine, professeur de biochimie et directeur du Whitaker Cardiovascular Institute à la faculté de médecine de l'université de Boston, ainsi que médecin en chef du Boston Medical Center. Il est l'un des fondateurs de NitroMed, Inc. et siège à son conseil d'administration et préside son conseil consultatif scientifique. En 2004, il est devenu rédacteur en chef de Circulation, une revue scientifique de premier plan en cardiologie. Le Dr Loscalzo a obtenu son diplôme A.B., summa cum laude, son doctorat en biochimie et son doctorat en médecine à l'Université de Pennsylvanie. Il a rejoint la faculté de Harvard et le personnel du Brigham and Women's Hospital en 1984. Il a rejoint la faculté de l'Université de Boston en 1994, d'abord en tant que chef du service de cardiologie et, en 1997, en tant que président du service de médecine. Le Dr Loscalzo est le président sortant du Cardiovascular Board de l'American Board of Internal Medicine et le président sortant du Board of Scientific Counselors du NHLBI. Il a été professeur invité dans de nombreuses institutions et est l'auteur ou le co-auteur de plus de 400 publications scientifiques et de 20 livres. Il a également reçu de nombreuses subventions du NIH et de l'industrie pour ses travaux dans les domaines de la biologie vasculaire, de la thrombose et de l'athérosclérose au cours des vingt dernières années.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 36 330 ( 0,02% ) | 3 M $ | 31/05/2026 | |
| 20/04/2026 | 168 750 ( 0,16% ) | 190 688 $ | 31/05/2026 |
Postes actifs de Joseph Loscalzo
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Président | 02/06/2021 |
| CYPHERPUNK TECHNOLOGIES INC. | Directeur/Membre du Conseil | 01/01/2016 |
Brigham Medical Research & Educational Foundation, Inc. | President | - |
Brigham Community Practices, Inc. | Directeur/Membre du Conseil | - |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Consultant / Advisor | - |
Scipher Medicine Corp.
 Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Fondateur | 01/01/2013 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Joseph Loscalzo
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Joseph Loscalzo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Cardiovascular Sciences, Inc.
 Cardiovascular Sciences, Inc. Other Consumer ServicesConsumer Services Develops novel technology platform | Consumer Services |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
CB Health Ventures
 CB Health Ventures Investment ManagersFinance CB Health Ventures focuses on investment opportunities in healthcare services, medical information technology, biotechnology and genomics | Finance |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Brigham & Women's Faulkner Hospital, Inc.
 Brigham & Women's Faulkner Hospital, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that Provides health care services | Commercial Services |
Boston Medical Center
 Boston Medical Center Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Commercial Services |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
Excel Medical Ventures LLC
 Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Finance |
National Heart, Lung & Blood Institute
 National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Whitaker Cardiovascular Institute
 Whitaker Cardiovascular Institute The Whitaker Cardiovascular Institute is a research laboratory located in the Department of Medicine at Boston University School of Medicine. The lab focuses on studying endothelial cells and understanding vascular diseases, with a particular interest in the role of endothelial cells in the cardiovascular system. The company's research interests include understanding the molecular and cellular mechanisms that regulate vascular inflammation, endothelial dysfunction, pulmonary microvascular injury in sepsis, arterial vascular dysfunction, and atherosclerosis, developing non-invasive methods to measure in vivo vascular function, and exploring endothelial cell-targeted therapies for lung and cardiovascular diseases. The laboratory has a strong track record of research productivity and has expanded their research to cover topics such as cardiovascular physiopathology, redox biology, redOX proteomics, and optical vascular imaging. Whitaker Cardiovascular Institute is based in Boston, MA. | |
Scipher Medicine Corp.
Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Commercial Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Brigham Community Practices, Inc. | |
Brigham Medical Research & Educational Foundation, Inc. |
